📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
In 2024, Dexcom completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Dexcom has also provided a category-level breakdown for 12 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Dexcom’s data sources below and access millions more through our Disclosure Search.
In 2024, the total operational greenhouse gas (GHG) emissions ofDexcom amounted to44,523metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Dexcomincreased by 41.98%, suggesting that the company faced challenges in reducing its emissions from its core operations.ab
In 2024, the total Scope 1 emissions of Dexcom were 8,328 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Since 2020, Dexcom's Scope 1 emissions have increased by 307.44%, reflecting a rising long-term trend in Scope 1 emissions over time.a
Compared to the previous year(2023), Dexcom's Scope 1 emissions increased by 17.63%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2024, Dexcom reported Scope 2 greenhouse gas (GHG) emissions of 33,612 tCOâ‚‚e using the market-based method and 36,195 tCOâ‚‚e using the location-based method.a
Since 2020, Dexcom's Scope 2 greenhouse gas (GHG) emissions (Location-Based)have increased by 293.38%, reflecting a rising long-term trend in Scope 2 emissions over time.a
Compared to the previous year(2023), Dexcom's Scope 2 emissions(Location-Based) rose by 49.08% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energyab
In 2024, Dexcom reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2024, Dexcom reported 551,767 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of Dexcom includes a breakdown across 12of the 15 Scope 3 categories defined by the GHG Protocol,matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2024, Dexcom reported total Scope 3 emissions of 551,767 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
Approximately 98.19%of these emissions originated from upstream activities such as purchased goods and capital goods, while 1.81%came from downstream activities like product use, distribution, and end-of-life treatment.a
Since 2020, Dexcom's Scope 3 emissionshave increased by 43,795.54%, reflecting a rising long-term trend in Scope 3 emissions over time.a
Compared to the previous year (2023), Dexcom's Scope 3 emissions increased by 15.05%, suggesting that the company faced challenges in reducing emissions across its value chain.a
In 2024, Dexcom reported emissions for 12 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This reflects a high level of granularity and transparency in the company's emissions reporting.
In 2024, the largest contributors to Dexcom's Scope 3 emissions were:a
In 2024, Dexcom reported Scope 1 greenhouse gas (GHG) emissions of 8,328 tCOâ‚‚e and total revenues of USD 4,033 millions. This translates into an emissions intensity of 2.07 tCOâ‚‚e per millions USD.a
In 2024, Dexcom reported a Scope 1 emissions intensity of 2.07 tCOâ‚‚e per millions USD. Compared to the peer group median of 4.04, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2024, Dexcom ranked 8 out of 22 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
Dexcom is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a
In 2024, Dexcom reported a total carbon footprint of 596,290 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 16.71% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.ab
The largest contributor to Dexcom's total carbon footprint was Scope 3 emissions, accounting for 92.53% of the company's total carbon footprint, followed by Scope 2 emissions at 6.07%.a